The relatively low success rates for bio/pharmaceutical compounds in clinical development have prompted many organizations to explore ways of reducing risk in clinical development.
Janis Hall
Advertisement
Janis Hall is a senior consultant at The Avoca Group
Articles by Janis Hall
Advertisement
Latest Updated Articles
Managing Clinical Development Risk: Pharma and CRO ReportPublished: February 1st 2014 | Updated:
Advertisement
Advertisement
